Stonepine Capital Management, LLC Quant / Systematic

CIK: 0001440771 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value ($000): $126,058 (100.0% shares, 0.0% debt)

Holdings (20)

EOLS EVOLUS INC 29.7%
Value ($000) $37,441 Shares 2,674,356 Est. Cost $8.66 Unrealized +50.1%
ADMA ADMA BIOLOGICS INC 17.9%
Value ($000) $22,617 Shares 3,426,882 Est. Cost $2.26 Unrealized +141.4%
ALIMERA SCIENCES INC 12.5%
Value ($000) $15,799 Shares 4,051,072 Est. Cost $3.11 Unrealized
GLPG GALAPAGOS NV-SPON ADR 10.1%
Value ($000) $12,675 Shares 393,634 Est. Cost $36.89 Unrealized
REVANCE THERAPEUTICS INC 7.7%
Value ($000) $9,724 Shares 1,976,342 Est. Cost $4.92 Unrealized
XOMA XOMA CORP 4.8%
Value ($000) $6,103 Shares 253,770 Est. Cost $19.74 Unrealized +13.5%
TELA TELA BIO INC 3.1%
Value ($000) $3,902 Shares 688,200 Est. Cost $8.26 Unrealized -20.2%
NEKTAR THERAPEUTICS 2.6%
Value ($000) $3,251 Shares 3,480,409 Est. Cost $0.93 Unrealized
MIST MILESTONE PHARMACEUTICALS IN 2.1%
Value ($000) $2,618 Shares 1,462,296 Est. Cost $1.62 Unrealized 0.0%
SCPHARMACEUTICALS INC 1.8%
Value ($000) $2,243 Shares 446,776 Est. Cost $5.02 Unrealized
CALC CALCIMEDICA INC 1.7%
Value ($000) $2,174 Shares 522,602 Est. Cost $4.55 Unrealized 0.0%
ANIK ANIKA THERAPEUTICS INC 1.2%
Value ($000) $1,548 Shares 60,949 Est. Cost $24.20 Unrealized 0.0%
RIGEL PHARMACEUTICALS INC 1.2%
Value ($000) $1,540 Shares 1,040,241 Est. Cost $1.48 Unrealized
AYTU AYTU BIOPHARMA INC 1.1%
Value ($000) $1,436 Shares 472,469 Est. Cost $1.96 Unrealized +45.7%
XERS XERIS BIOPHARMA HOLDINGS INC 1.0%
Value ($000) $1,322 Shares 598,086 Est. Cost $2.16 Unrealized +20.0%
XGN EXAGEN INC 0.5%
Value ($000) $612 Shares 384,600 Est. Cost $8.92 Unrealized -78.2%
ADICET BIO INC 0.3%
Value ($000) $333 Shares 141,548 Est. Cost $2.35 Unrealized
RZLT REZOLUTE INC 0.2%
Value ($000) $310 Shares 121,479 Est. Cost $3.88 Unrealized -63.4%
IOBT IO BIOTECH INC 0.2%
Value ($000) $270 Shares 156,167 Est. Cost $1.76 Unrealized -1.2%
SCYX SCYNEXIS INC 0.1%
Value ($000) $141 Shares 95,637 Est. Cost $2.73 Unrealized -35.3%